M.Sc

Aculife Healthcare Private Limited, a part of renowned Nirma Group, is one ot the world's largest manufacturer of parenteral, and pharmaceutical formulations under one roof Aculife has been associated with the healthcare segment since over last 30 years now. which is the prime reason why the name spells unparalleled growth and absolute relibility. it has global operations spread across 70 countries including WOS in Mexico and JV in Brazil. Presently, the Company has 8 manufacturing plants backed up by state of the art Aculife Research Centre & 3000 plus Employee base in India & abroad.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies and has received various certifications including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and AAALAC.

Post : Senior Research Associate - ARD 1

The Indian Institute of Science Education & Research (IISER) Mohali was established in 2007 by the Government of India, through the Ministry of Human Resource Development (MHRD), to carry out research in frontier areas of science and to provide quality science education at the undergraduate and postgraduate level. The foundation stone was laid on 27^th September 2006 by the Prime Minister of India. The first Director Prof.N Sathyamurthy joined on 18^th June 2007. Classes for the first MS (Int) batch began on 16^th August 2007. The transit campus was inaugurated on 13^th Nov. 2007.

Post : Project Assistant

Founded in Germany in 1839  and with over 60,000 employees in 64 countries, B. Braun is one of the world's largest medical technology companies, specializing in solutions related to infusion therapy, orthopaedics, neurosurgery, anaesthesia, extracorporeal blood treatment, spine surgery, diabetes care, clinical nutrition, wound management, infection prevention and surgical technologies. Through constructive dialogue, B. Braun develops high quality product systems and services that are both evolving and progressive - and in turn, improves people's health around the world. In 2015, the Group generated sales of approximately €6.13 billion.

Post : Therapy Specialist

We are a biopharmaceutical company pioneering the application of artificial intelligence and big data analytics integrated with drug development expertise. We use our proprietary platforms to advance the next wave of medicines and significantly improve the clinical and regulatory success of drug development.  Our goal is to develop innovative medicines in immuno-oncology, neuroscience, and rare diseases with high unmet need. We believe that our Research & Development Engine can result in a disruptive change that will impact pharma productivity and innovation to benefit the entire healthcare ecosystem.

Post : INTERNSHIP - for Gurgaon and Delhi Candidates Only

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Medical Science Liaison

Anna University Chennai Regional Office Tiruchirappalli (Formerly Anna University Tiruchirappalli) has been established as a Anna University Chennai Regional Office Tiruchirappalli by the Government of Tamilnadu. The Regional Office is functioning from 01-08-2012 at Tiruchirappalli, which is famously known as Rock Fort city. The Regional Office is situated 17Kms away in the main highway of Tiruchirappalli to Pudukkottai.

Post : Junior Research Fellow

NISER recognizes that modern scientific research is carried out in interstices amongst fuzzy domains and blurred boundaries. This entails encouraging a new scientific culture where members of our community attain to an intellectual agility unconstrained by the limitations of disciplinary conventions from the past. Faculty and Students will be given generous material support in the pursuit to realize this objective. Time and conversational space will be devoted to nascent propositions and hypothesis and the significantly small student-faculty ratio, an eventual full strength of 2000 students and 300 faculty, manifests the Institutes investment and hope in the future.